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Both clinical and experimental studies indicate that irffections due to Fried- 
l~nder's  bacillus  may  be  favorably  affected  by  sulfonamide  chemotherapy 
(1-12).  Little is known, however, concerning the mechanism of recovery from 
such infections in either human patients  or laboratory animals.  In  the pre- 
ceding paper the pathogenesis of experimental Friedliinder's pneumonia in  rats 
was  described  (13).  The  disease  produced  resembled  acute  Friedliinder's 
pneumonia in man.  The present  report deals with  the effect of sulfonamide 
chemotherapy upon the pulmonary lesion of this experimental infection. 
Metkods 
The detailed techniques employed in the production of experimental Friediiinder's bacillus 
pneumonia in white rats have already been described (13).  The pneumonia produced was 
almost uniformly fatal in untreated animals.  Blood cultures  were taken from the tail at 
frequent intervals during the course of the infection, and all lungs were fixed in Zenker-formol 
solution according to the method of Loosli (14).  "i~issue  sections were stained by the Gram- 
Weigert technique  (15). 
Sulfonamide Treatment.~Either  powdered sulfadiazine  or powdered sulfarnerazine  I was 
used in all experiments.  Five gin. of the powdered drug was added to 100 mh of a 10 per cent 
gum acacia mixture, and appropriate amounts of the resulting suspension were introduced into 
the stomach through a blunt cannula by way of the mouth.  Three hundred mg. of sulfa- 
diazine (6 ml.) was given as an initial dose, at the end of 12 hours and every 24 hours there- 
after.  When sulfamer~zlnewas used, 24 hour maintenance doses of 200 rag. (4 ml.) were found 
to be sufficient to maintain an adequate blood level.  The concentrations of drugs maintained 
in the blood by the two dosage schedules in both normal and infected animals are charted 
in  Text-fig.  1. 
Teats  for A ntibody.--The methods used to detect circulating antibodies against Friedliinder's 
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bacillus included the standard mouse protection test (16) and a microscopic test for opsonins 
and agglutinins.  In the mouse protection test 0.2 ml. of pooled serum (obtained from four to 
six rats) was injected intraperitoneally together with 0.2 ml. of tryptose broth containing 
5 per cent para-aminobenzoic acid  s and approximately 50 Friedl~inder's bacilli.  Five mice 
were used in testing each lot of pooled serum, and the final results of the tests were tabulated 
at the end of 1 week.  The procedure used in testing for opsonins and agglutinins was as 
follows.  Washed  Friedlgnder's bacilli obtained from 0.25  ml.  of a  4  hour culture  of  the 
organisms in serum infusion broth were suspended in 0.1 mi. of the test serum, together with 
leucocytes obtained from peritoneal exudate of rats (17).  The mixture was placed on a glass 
slide and incubated for 30 minutes in a  sealed Petri dish lined with moist filter paper (17). 
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TExT-FIo.  1.  Sulfonamide blood levels in normal rats and rats with experimental pneu- 
monia treated by mouth with sulfaraerazine and sulfadiazine.  Each point on the curves 
represents the average of values obtained on five or more animals.  (For dosage, see text.) 
At the end of the period of incubation smears were made and stained with methyIene blue. 
Both phagocytosis and agglutination of extracellular organisms were considered in recording 
the final results of the tests on each lot of serum. 
~ESULTS 
)Effect of Sulfonamide  Chemottterapy  upon  Fatality  Rate.--When  treatment 
with either sulfadiazine or sulfamerazine  a was begun 6  hours after inoculation 
more  than  90  per  cent  of  the  animals  survived  the  infection.  As  shown  in 
2 To neutralize the bacteriostatic effect of the sulfonamide contained in the rat serum. 
a At no time was any appreciable difference noted in the effect of sulfadiazine and sulfameri- 
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Table I, there were two deaths from pneumonia  among the 33 rats so treated. 
More than half of these animals were allowed to survive longer than  10 days 
before  being  sacrificed.  When  treatment  was  withheld  until  9  hours  after 
inoculation, the survival rate was appreciably lower, and after 12  hours  only 
half of the animals survived the pneumonia.  Treatment begun 18 hours after 
inoculation  appeared  to  have  no  appreciable  effect  upon  the  course  of  the 
infection.  In all subsequent  treatment experiments sulfonamide therapy was 
started 6  hours  after inoculation. 
Effect of Sulfonamide Chemotherapy  upon the Gross Pneumonic Lesion.--The 
action of sulfonamide chemotherapy upon the pulmonary lesion was studied in a 
series of treated rats sacrificed at 6,  18, 24, 36, 42, 66, 90, and 168 hours after 
the start of treatment.  Three rats were killed at each interval, and the lungs 
were  examined  in  the  gross  before  being  fixed  for  histological  study 
(Text-fig. 2). 
TABLE I 
Surtival Rate  among Rats  with  Experimental  Friedlander's  Pneumonia Treated  with  Sul  fonamide 
at Various Intervals after Inoculation 
No. of rats surviving  Time after inoculation  No. of rats treated  Sm'vival 
that treatment  was begun  pneumonia 
/~rL. 
6 
9 
12 
18 
33 
19 
10 
9 
31 
14 
6 
0 
~ef C~n| 
94 
73 
6O 
0 
Six hours after the start of treatment the gross lesion occupied about half the left lung and 
was bright red in color.  The border between the normal and consolidated lung was hemor- 
rhagic and irregular, presenting the same appearance as in untreated animals 12 hours after 
inoculation (13).  Both the size of the lesion and the character of its border indicated that 
the drug had exerted little or no effect upon the spreading pneumonia during the first 6 hours 
of treatment.  At 18 hours the lesion was slightly larger, but its margin was now sharp and 
lacked the irregular hemorrhagic appearance noted at 6 hours.  Thereafter there occurred no 
further spread of the pneumonia, and at 24, 36, and 42 hours the lesion became grayer and 
more firm in consistency.  After 66 and 90 hours of treatment the area of consolidation ap- 
peared to be slightly smaller than at 18 hours, and definite contraction of the hard gray lesion 
was noted at the end of 1 week.  At each of the above intervals the site of the original mucin 
inoculation was identifiable as a dark red area which differed in color from the pneumonic 
lesion and failed to spread. 
In marked contrast to the pathological findings in untreated animals (13) neither pleurisy 
nor pericarditis  was noted in rats sacrificed during sulfonamide therapy. 
Effect of Chemotherapy upon Bacteremia.--Frequent  blood cultures were taken 
during the course of treatment; the results are recorded in Text-fig. 2.  After 
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animals.  At no later time, however, did the incidence exceed 15 per cent, and 
after 1 week's treatment all blood cultures were sterile. 
Histopathology of Pulmonary Lesion in  Treated Animals.--Tissue  sections 
were studied from the lungs of all of the rats sacrificed at the intervals stated in 
Text-fig. 2.  Additional rats were also killed at 3,  18,  and 24 hours after the 
start of treatment, and the lungs of three animals at each interval were~x- 
amined histologically to determine the effect of treatment upon the lesion. 
Time after 
Treatment 
Approximate 
Size  of 
Pulmonary 
Lesion  ° 
5  hours 8  hours  ¢2  hours  66  hour~,  )0  hours  I  week  Unlreated  l~a~$" 
Blood  Culture  7  2  0  2  I  0  5 
Positive 
Blood  Culture  6  ii  15  12  14  15  0 
Negative 
Incidence  of  54~  15%  O#  14%  7%  07"  I00~'o 
Bacteremia 
• Based  on autopsy findinqs in 5  ra%s killed  a~ each interval 
"'Un'~reated  ra'cs  died  in  less  fhan  lO0  hours 
TmxT-Fm. 2. Effect of sulfonamide chemotherapy upon pulmonary lesion and incidence 
of bacteremia in experimental Friedl~inder's pneumonia.  Treatment begun 6 hours  after 
inoculation. 
As shown in Fig. 1, the morphology of the FriedlRnder bacilli in the outer edema zone at the 
end of 3 hours of therapy appeared to be normal.  Examination  of the rest of the lesion 
revealed it to be identical with the early pneumonia observed in untreated animals.  After 6 
hours of treatment, the edema zone was still prominent (Fig. 2), but the Friedl~inder  baciifi 
in the edema-fiUed alveoli were now noted to be enlarged, pleomorphic, and irregularly 
stained (Fig. 3), indicating bacteriostasis  (18).  At 18 hours the edema zone was no longer 
present at the margin of the lesion (Fig. 4), and the pneumonic process appeared to have 
stopped spreading.  In the outermost alveoli, where the bacteria were most plentiful, at both 
18 and 24 hours, organisms could be seen in the cytoplasm of the polymorphonuclear leucocytes 
(Fig. 5).  After 36 hours of treatment phagocytosis of the bacteria  appeared  to be more 
complete (Fig. 6), and at later intervals large mononuclear cells could be seen to be taking 
part in the phagocytic process (Fig. 7).  At the end of 90 hours the alveolar exudate  was 
predominantly mononuclear; extracellular bacteria  were now no longer visible and most of 
the intra~ellular organisms appeared to have been digested by the phagocytes (Fig. 8),  Signs 
of clearing of the pneumonic process were prominent at the end of the 7 day period of treat- 
ment. 
The Effect of Sulfonamide Tkerapy upon the Formation of Abscesses in the 
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at  the  time of autopsy.  The incidence of abscess formation was higher in 
aD]rnais treated  12 hours after inoculation than in those treated at 6  hours. 
In  one experiment treatment was  begun  6  hours after inoculation and  was 
maintained for a period of 2 weeks.  Two rats so treated and sacrificed on the 
35th day had small but definite lung abscesses from which Friedliinder's bacilli 
were recovered in pure culture. 
The Relation of Phagocytosis  in the Lung to the Presence of Circulating Anti- 
body.--(rhe serum from suifonamide-treated rats recovering from Friedliinder's 
bacillus pneumonia was tested for mouse-protective, opsonizing, and  aggluti- 
nating antibodies at the end of the 1st, 2nd, 3rd, 4th, and 7th days of treatment. 
Although phagocytosis was prominent in the lungs within the first 24 hours of 
treatment, no antibody could be detected in the  blood serum until after 4 or 
more days of treatment (see Table II). 
TABLE H 
Te~s for Antibody in Serum of Ra~s wi~k Experimo~lal Friedlander'$ Pneumonia Treated 
~.,~k S~ ror~rnide 
Duration of pneumonla  Mouse protection test*  Opsonecytophagic  test  Anluttnatlon test 
24 
48 
72 
96 
0-5 
1-5 
0-5 
0-5 
3-5 
o  o 
o  o 
o  o 
o 
+  + 
* First figure  indicates  number of mice surviving  at end of 1 week; second figure  refers to 
number of mice  inoculated. 
DISCUSSION 
Friedliinder's bacillus  pneumonia  induced  in  white  rats  by  the  methods 
described in the present studies (and not treated) constitutes an acute pulmonary 
infection which is almost uniformly fatal.  Although somewhat more fuLmi- 
nating in its course than human Friedl~nder's pneumonia, the experimental 
murine infection resembles very closely the acute form of the human disease 
(13).  The experiments here reported show that the experimental pneumonia in 
rats, in spite of its fnlmlnant character, can be controlled by adequate sulfona- 
mide therapy provided the  drug is administered early in  the disease.  The 
manner in which the drug exerts its beneficial effect is revealed by the histology 
of the recovery process in the lung. 
In the untreated animal Friedl~'lder's bacilli appear to cause consolidation of 
the lung by the same mechanism as does the pneumococcus (15).  The organ- 
isms can be seen in large numbers in the outer edema zone of the lesion where 
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producing a spread of the lesion.  As in experimental pneumococcal pneumonia 
(19) suLfonamide  chemotherapy appears to exert its main effect in this spreading 
edema zone.  Six hours after the start of treatment the Friedliinder  bacilli in 
the edema-filled alveoli exhibit morphological changes indicative of bacteriosta- 
sis  (18), and shortly thereafter the pneumonic  lesion ceases to  spread.  The 
appearance  of edema fluid in the outermost portion of the spreading  lesion 
constitutes the earliest  stage of inflammation in the infected  alveoli.  When 
the lesion stops spreading as the result of bacteriostasis, phagocytes accumulate 
in all of the infected alveoli that previously contained only edema fluid, and 
since no further spread of the infection occurs, the edema zone disappears from 
the margin of the lesion.  Once phagocytes have accumulated in sufficient 
number in the infected alveoli, they destroy the bacilli by the same phagocytic 
process that operates  in the zone of consolidation  in untreated animals (13). 
The sulfonamide drug brings about recovery by inhibiting the growth of the 
bacteria at the advancng margin of the lesion, thereby enabling the alveolar 
phagocytes to destroy the bacteria that have invaded the lung.  Only in areas 
of abscess formation do the phagocytes fail to destroy all of  the  offending 
organisms. 
Although from these studies little doubt appears to exist as to the manner in 
which sulfonamide chemotherapy causes recovery in Friedliinder's  pneumonia, 
the exact mechanism involved in the phagocytosis and ultimate destruction of 
the  bacteria  remains  obscure.  Friedliinder's  bacillus,  like  pneumococcus, 
possesses a protective capsule which renders the organism resistant to phago- 
cytosis.  Why then should  phagocytosis  occur  in the pneumonic lesions of 
boLh treated and untreated animals?  In the case of experimental pneumococcal 
pneumonia (18), phagocytosis is observed in the first 24  hours of the infection 
and occurs even in the lungs of bacteremic animals.  Thus it appears unlikely 
that circulating antibody is responsible for the phagocytic reaction.  Likewise, 
in the present experiments, no antibody could be detected in the blood of rats 
recovering from Friedli~nder's pneumonia until several days after phagocytosis 
had begun in the lungs.  All of the evidence thus far advanced indicates that 
the ultimate recovery of animals with Friedliinder's  pneumonia when given 
sulfonaxnide depends upon the phagocytosis of the offending bacteria, and yet 
no satisfactory explanation  can be given for the occurrence of phagocytosis  of 
the encapsulated  organisms in the absence of opsonins.  Therefore, further ex- 
periments have been carried out to elucidate the exact mechanism of this non- 
antibody phagocytic reaction in the lung, and to determine the reason for its 
failure to operate efficiently in areas of abscess formation.  The results of these 
experiments  are reported in the following paper. 
SUMMARY 
Sulfonamide chemotherapy was found to cure rats of an otherwise fatal form 
of experimental Friedliinder's bacillus pneumonia when treatment was begun 6 L.  SALE~ ~'R.~ M.  R.  SMITI~,  AND  W.  B.  WOOD~ yR.  255 
hours  after inoculation.  Most of the pneumonic lesions cleared  completely, 
but an  occasional animal  exhibited small residual abscesses in the previously 
consolidated lung. 
The recovery process taking place in the lungs was studied histologically at 
various intervals during therapy.  As in the case of pneumococcal pneumonia, 
the principal action of the sulfonamide was upon the bacteria in the advancing 
edema  zone  at  the  periphery  of  the  pneumonic  lesion.  The  bacteriostatic 
action  of the  drug  appeared  to  stop the  spread  of the pneumonia,  and  the 
Friedliinder  bacilli were ultimately ingested and destroyed by the phagocytic 
cells in the alveolar exudate. 
The phagocytosis of bacteria in the lung was shown to be unrelated  to the 
presence of antibody in the blood. 
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EXPLANATION OF  PLATES 
Tissue  sections  from the  lungs  of rats  with  experimental  Friedl~der's  bacillus 
pneumonia  treated  with  sulfonamide.  Fig.  5  was  photographed by Mr.  Cramer 
Lewis; the remaining figures by Mr. Milton K. Echtold.  All sections were stained by 
the  Gram-Weigert  technique. 
PLATE 25 
FIG. 1. Bacteria-hden edema fluid in alveolus at margin of spreading lesion 3 hours 
after the start of treatment.  The bacterm as yet exhibit  none of the characteristic 
morphological  signs  of  bacteriostasis.  X 1500. 
Fro. 2.  Edema zone still present at margin of lesion 6 hours after the start of treat- 
ment.  X 200. 
Fzo. 3.  Pleomorphism of Friedl~nder's  bacilli, indicating  early bacteriostatic  effect 
after 6 hours of treatment.  X 1500. 
Fro.  4. D/sappe~rance  of edema  zone from the margin of lesion  18 hours after 
beginning  of treatment.  X 200. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL. 86  PLATE  25 
(Sale  el al.: Mechanism of recovery in pneumonia.  II) PLATE 26 
FIG. 5.  Early phagocytosis of Friedl/~nder's bacilli in rat sacrificed at end of 24 hours 
of treatment.  X  1500. 
FIo. 6.  More complete phagocytosis of FriedlAnder's  bacilli by leucocytes in alveolar 
exudate after 36 hours of treatment.  X 500. 
FIG. 7.  Macrophage reaction with a few intracellular organisms.  This animal was 
sacrificed 66 hours after the start of treatment; the macrophage is the predominant 
cell.  >  855. 
FIG. 8.  Lesion after 1 week of treatment showing marked clearing with only macro- 
phages in the alveoli.  Bacteria are no longer visible in the cytoplasm of the phago- 
cytes.  X  1000. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  86  PLATE  26 
(Sale et al.:  Mechanism of recovery in pneumonia.  II) 